Latest Cordis Stories
NEW BRUNSWICK, N.J., May 28, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the acceptance of the March 1, 2015 binding offer from Cardinal Health to acquire its Cordis
Cordis Is A Worldwide Leader In Cardiac And Endovascular Medical Products DUBLIN, Ohio, May 28, 2015 /PRNewswire/ -- Cardinal Health today announced that its March 1, 2015 binding
LONDON, May 21, 2015 /PRNewswire/ -- PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a
First Carotid Stent Indicated for Transcarotid Use and Optimized for Novel TransCarotid Artery Revascularization (TCAR) Procedure SUNNYVALE, Calif., May 19, 2015 /PRNewswire/ -- Silk
NEW BRUNSWICK, N.J., March 2, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced a binding offer from Cardinal Health to acquire its Cordis business for an
- Significantly advances Cardinal Health's offering of interventional cardiology and endovascular solutions for integrated health systems and their patients - Creates immediate
The peripheral vascular medical device market will be driven by technological advances, but regional differences and a diverse competitive landscape may make growth challenging, says new report
FREMONT, Calif., Nov.
MarketOptimizer.org adds “MediPoint Aortic Stent Grafts – Global Analysis and Market Forecasts” to its store.
Market Size - $1,514.7 million in 2013, Market Growth - CAGR of 5.5%, Market Trends - Growing demand for minimally invasive surgeries.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.